Azlocilline and HR 756 in urosepsis and urinary tract infection with multiresistant pseudomonas and proteus morganii
Pils, P.; Schmidt, P.; Zazgornik, J.; Graninger, W.; Kopsa, H.; Balcke, P.; Schimatzek, A.
Deutsche Medizinische Wochenschrift 104(2): 66-67
1979
ISSN/ISBN: 0012-0472 PMID: 252458 Document Number: 141044
Document emailed within 1 workday
Related Documents
Penner, S.J.; George, J.; Claflin, L. 1995: Initiation of the phosphocholine-specific response to Proteus morganii. B cell transfectants expressing unmutated VH/VL can respond to stimulation by P. morganii antigen Journal of Immunology 155(5): 2387-2395Budhraja, S.N.; Sharma, K.B.; Muralidharan, S. 1971: Clinical evaluation of gentamicin in Pseudomonas pyocyaneus infection of the urinary tract Indian Journal of Medical Sciences 25(12): 862-866
Murahashi, I.; Honda, M.; Maeda, S.; Takasaki, E. 1982: Clinical study on netilmicin in the treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa Japanese Journal of Antibiotics 35(8): 1919-1924
Okamoto, Y.; Maehara, K.; Ueda, Y.; Nasu, M.; Kamiki, T.; Iri, H.; Nagai, T.; Kumamoto, Y.; Sakai, S.; Shigeta, S.; Kosaki, N.; Oguri, T. 1981: Comparison of antibacterial activity of oral antibacterial agents against recently isolated bacteria of E. coli, Klebsiella, Citrobacter and Proteus from clinical materials of urinary tract infection Japanese Journal of Antibiotics 34(6): 959-975
Tomioka, H.; Kobayashi, Y.; Shigeta, Y. 1977: Therapeutic experience of Proteus morganii septicemia with amikacin Japanese Journal of Antibiotics 30(8): 593-595
Maurya, A.Prakash.; Choudhury, D.; Talukdar, A.Das.; Dhar Chanda, A.; Chakravarty, A.; Bhattacharjee, A. 2014: A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India Indian Journal of Medical Research 140(4): 565-567
Claflin, J.L.; George, J.; Dell, C.; Berry, J. 1989: Patterns of mutations and selection in antibodies to the phosphocholine-specific determinant in Proteus morganii Journal of Immunology 143(9): 3054-3063
Aboulker, P.; Bernard, E.; Thomas, J. 1971: Primary phosphatic lithiasis in adult woman with urinary proteus infection Annales d'Urologie 5(1): 1-5
Kreĭnin, L.S.; Egorova, N.B.; Stanislavskiĭ, E.S.; Kaverina, K.G.; Levina, L.A. 1983: Combined Staphylococcus-Proteus-Pseudomonas vaccine. II. the toxicity of the vaccine in "chronic" experiments and its ability to protect animals against Proteus and Staphylococcus infections Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 87-92
Worlitzsch, D.; Wolz, C.; Botzenhart, K.; Hansis, M.; Burgdörfer, H.; Ogle, J.W.; Döring, G. 1989: Molecular epidemiology of Pseudomonas aeruginosa--urinary tract infections in paraplegic patients Zentralblatt für Hygiene und Umweltmedizin 189(2): 175-184
Tapaneya-Olarn, C.; Tapaneya-Olarn, W.; Assadamongkol, K. 1989: Genitourinary tract anomalies in Thai children with urinary tract infection Journal of the Medical Association of Thailand 72(Suppl 1): 47-51
Takeuchi, H.; Okada, Y.; Yoshida, O.; Konishi, T.; Tomoyoshi, T.; Nakahara, S. 1989: Urinary tract infection associated with urinary calculi. 2. Effects of antibiotics on bacteria within infected stones Hinyokika Kiyo. Acta Urologica Japonica 35(5): 755-761
Johnson, C.E.; Vacca, C.V.; Fattlar, D.; Fulton, D.J.; Hall, P.W. 1990: Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection Pediatrics 86(2): 211-216
Watine, J.; Bourrel, C.; Dubourdieu, B.; Gineston, J.L.; Bories, P.; Durand, M.; Marre, A.; Formosa, F.; Brunel, M.P.; Palliez, J. 1994: Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics Pathologie-Biologie 42(4): 293-295
Fujimura, N.; Yuasa, K.; Uema, K.; Kurokawa, K. 1984: Clinical studies on combination therapy of cephem antibiotics in chronic complicated urinary tract polymicrobial infections due to Pseudomonas aeruginosa and other bacteria Japanese Journal of Antibiotics 37(9): 1669-1678
Gomes, M.Zenaide.Ribeiro.; Oliveira, R.Vasconcellos.C.de.; Machado, C.Romero.; Conceição, M.de.Souza.da.; Souza, C.Vieira.de.; Lourenço, M.Cristina.da.Silva.; Asensi, M.Dutra. 2012: Factors associated with epidemic multiresistant Pseudomonas aeruginosa infections in a hospital with AIDS-predominant admissions Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 16(3): 219-225
Delisle, F.; Lesage, D.; Barakett, V.; Richard, G.; Petit, J.C. 1996: In vitro study of the bacteriostatic and bactericidal activity of meropenem against strains of Pseudomonas aeruginosa multiresistant to antibiotics Pathologie-Biologie 44(5): 337-340
Zurina, Z.; Rohani, A.; Neela, V.; Norlijah, O. 2012: Late onset group b beta-hemolytic streptococcus infection in a neonate manifesting as a urinary tract infection: a rare clinical presentation Southeast Asian Journal of Tropical Medicine and Public Health 43(6): 1470-1473
Sheina, E.P.; Arutcheva, A.A. 1983: Pseudomonas aeruginosa and Proteus sensitivity to antibiotics and their combinations when cultured together Antibiotiki 28(5): 331-335
Wijesinha, S.S. 2001: Urinary tract infection. Are we getting it right? Australian Family Physician 30(4): 343-345